RAPP
RAPP
NASDAQ · Pharmaceuticals

Rapport Therapeutics Inc

$39.83
-0.17 (-0.43%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +13.4% upside
Low Target $32.24
Average Target $45.18
High Target $61.72
Current Price $39.83
Current
$39.83
Target
$45.18
$32.24 $45.18 avg $61.72
Scenario Analysis
Bear Case
$32.24
-19.1%
Low target
Base Case
$45.18
+13.4%
Avg target
Bull Case
$61.72
+55.0%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$42.27
-5.8% from high
52-Week Low
$10.51
+279.2% from low
Target vs 52W High
$45.18
+6.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%